0.008331
0.004810
0.000000
0.000000
0.009620
0.000000
0.000000
0.000000
0.010552
0.000000
0.000000
0.000000
Joint Center for Structural Genomics (JCSG)
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
12
90.000
90.000
120.000
120.029
120.029
94.767
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 Se
196.106
n
SELENOMETHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
To be published
0353
Crystal structure of hypothetical protein BT_3535 (NP_812447.1) from
BACTERIODES THETAIOTAOMICRON VPI-5482 at 2.60 A resolution
10.2210/pdb3kny/pdb
pdb_00003kny
100
1
Flat mirror (vertical focusing)
CCD
2009-07-08
MARMOSAIC 325 mm CCD
Single crystal Si(111) bent monochromator (horizontal focusing)
MAD
M
x-ray
1
0.91162
1.0
0.97941
1.0
BL11-1
SSRL
0.91162,0.97941
SYNCHROTRON
SSRL BEAMLINE BL11-1
24645.857
hypothetical protein BT_3535
1
man
polymer
no
yes
GACEQNEDWVVNEP(MSE)QSFEENPEYAPLNTIPDWVSEKVTPKEYELWRT(MSE)SSRYEINYSFLKKDISEKRKKEI
YDCINNICERIEKGQINKYEGFLNIADEDGTTLSDSQYFGRIATRSPEGGAEYKTNGCTLYTHSLGPYIKAAVTYKKSDD
DVTITSSSVYTGSPYLGNDPSFSGASSVSYDKDKKLIAASCSGTLSFKDGSRKVEVTVQKTGF(MSE)IP
GACEQNEDWVVNEPMQSFEENPEYAPLNTIPDWVSEKVTPKEYELWRTMSSRYEINYSFLKKDISEKRKKEIYDCINNIC
ERIEKGQINKYEGFLNIADEDGTTLSDSQYFGRIATRSPEGGAEYKTNGCTLYTHSLGPYIKAAVTYKKSDDDVTITSSS
VYTGSPYLGNDPSFSGASSVSYDKDKKLIAASCSGTLSFKDGSRKVEVTVQKTGFMIP
A
393001
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
sample
BT_3535
226186
Bacteroides thetaiotaomicron VPI-5482
562
Escherichia Coli
HK100
Plasmid
SpeedET
1
4.00
69.23
VAPOR DIFFUSION, SITTING DROP
6.93
40.9000% 2-methyl-2,4-pentanediol, 0.1M HEPES pH 6.93, NANODROP, VAPOR DIFFUSION, SITTING DROP, temperature 277K
277
Joint Center for Structural Genomics
JCSG
PSI, Protein Structure Initiative
pdbx_struct_assembly_auth_evidence
software
software
struct_conn
database_2
struct_ref_seq_dif
repository
Initial release
Advisory
Version format compliance
Author supporting evidence
Refinement description
Data collection
Derived calculations
Refinement description
Database references
1
0
2009-12-01
1
1
2011-07-13
1
2
2017-10-25
1
3
2019-07-17
1
4
2023-02-01
_software.classification
_software.name
_software.classification
_software.contact_author
_software.contact_author_email
_software.language
_software.location
_software.name
_software.type
_software.version
_struct_conn.pdbx_leaving_atom_flag
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_struct_ref_seq_dif.details
Y
RCSB
Y
RCSB
2009-11-12
REL
REL
THE CONSTRUCT (RESIDUES 18-234) WAS EXPRESSED WITH A PURIFICATION TAG MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE LEAVING ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE.
n
1
0
A
n
2
18
A
n
3
19
A
n
4
20
A
n
5
21
A
ASN
22
n
6
ASN
22
A
GLU
23
n
7
GLU
23
A
ASP
24
n
8
ASP
24
A
TRP
25
n
9
TRP
25
A
VAL
26
n
10
VAL
26
A
VAL
27
n
11
VAL
27
A
ASN
28
n
12
ASN
28
A
GLU
29
n
13
GLU
29
A
PRO
30
n
14
PRO
30
A
MSE
31
n
15
MSE
31
A
GLN
32
n
16
GLN
32
A
SER
33
n
17
SER
33
A
PHE
34
n
18
PHE
34
A
GLU
35
n
19
GLU
35
A
GLU
36
n
20
GLU
36
A
ASN
37
n
21
ASN
37
A
PRO
38
n
22
PRO
38
A
GLU
39
n
23
GLU
39
A
TYR
40
n
24
TYR
40
A
ALA
41
n
25
ALA
41
A
PRO
42
n
26
PRO
42
A
LEU
43
n
27
LEU
43
A
ASN
44
n
28
ASN
44
A
THR
45
n
29
THR
45
A
ILE
46
n
30
ILE
46
A
PRO
47
n
31
PRO
47
A
ASP
48
n
32
ASP
48
A
TRP
49
n
33
TRP
49
A
VAL
50
n
34
VAL
50
A
SER
51
n
35
SER
51
A
GLU
52
n
36
GLU
52
A
LYS
53
n
37
LYS
53
A
VAL
54
n
38
VAL
54
A
THR
55
n
39
THR
55
A
PRO
56
n
40
PRO
56
A
LYS
57
n
41
LYS
57
A
GLU
58
n
42
GLU
58
A
TYR
59
n
43
TYR
59
A
GLU
60
n
44
GLU
60
A
LEU
61
n
45
LEU
61
A
TRP
62
n
46
TRP
62
A
ARG
63
n
47
ARG
63
A
THR
64
n
48
THR
64
A
MSE
65
n
49
MSE
65
A
SER
66
n
50
SER
66
A
SER
67
n
51
SER
67
A
ARG
68
n
52
ARG
68
A
TYR
69
n
53
TYR
69
A
GLU
70
n
54
GLU
70
A
ILE
71
n
55
ILE
71
A
ASN
72
n
56
ASN
72
A
TYR
73
n
57
TYR
73
A
SER
74
n
58
SER
74
A
PHE
75
n
59
PHE
75
A
LEU
76
n
60
LEU
76
A
LYS
77
n
61
LYS
77
A
LYS
78
n
62
LYS
78
A
ASP
79
n
63
ASP
79
A
ILE
80
n
64
ILE
80
A
SER
81
n
65
SER
81
A
GLU
82
n
66
GLU
82
A
LYS
83
n
67
LYS
83
A
ARG
84
n
68
ARG
84
A
LYS
85
n
69
LYS
85
A
LYS
86
n
70
LYS
86
A
GLU
87
n
71
GLU
87
A
ILE
88
n
72
ILE
88
A
TYR
89
n
73
TYR
89
A
ASP
90
n
74
ASP
90
A
CYS
91
n
75
CYS
91
A
ILE
92
n
76
ILE
92
A
ASN
93
n
77
ASN
93
A
ASN
94
n
78
ASN
94
A
ILE
95
n
79
ILE
95
A
CYS
96
n
80
CYS
96
A
GLU
97
n
81
GLU
97
A
ARG
98
n
82
ARG
98
A
ILE
99
n
83
ILE
99
A
GLU
100
n
84
GLU
100
A
LYS
101
n
85
LYS
101
A
GLY
102
n
86
GLY
102
A
GLN
103
n
87
GLN
103
A
ILE
104
n
88
ILE
104
A
ASN
105
n
89
ASN
105
A
LYS
106
n
90
LYS
106
A
TYR
107
n
91
TYR
107
A
GLU
108
n
92
GLU
108
A
GLY
109
n
93
GLY
109
A
PHE
110
n
94
PHE
110
A
LEU
111
n
95
LEU
111
A
ASN
112
n
96
ASN
112
A
ILE
113
n
97
ILE
113
A
ALA
114
n
98
ALA
114
A
ASP
115
n
99
ASP
115
A
GLU
116
n
100
GLU
116
A
ASP
117
n
101
ASP
117
A
GLY
118
n
102
GLY
118
A
THR
119
n
103
THR
119
A
n
104
120
A
n
105
121
A
n
106
122
A
n
107
123
A
n
108
124
A
n
109
125
A
n
110
126
A
n
111
127
A
n
112
128
A
n
113
129
A
n
114
130
A
n
115
131
A
n
116
132
A
n
117
133
A
n
118
134
A
n
119
135
A
n
120
136
A
n
121
137
A
n
122
138
A
ALA
139
n
123
ALA
139
A
GLU
140
n
124
GLU
140
A
TYR
141
n
125
TYR
141
A
LYS
142
n
126
LYS
142
A
THR
143
n
127
THR
143
A
ASN
144
n
128
ASN
144
A
GLY
145
n
129
GLY
145
A
CYS
146
n
130
CYS
146
A
THR
147
n
131
THR
147
A
LEU
148
n
132
LEU
148
A
TYR
149
n
133
TYR
149
A
THR
150
n
134
THR
150
A
HIS
151
n
135
HIS
151
A
SER
152
n
136
SER
152
A
LEU
153
n
137
LEU
153
A
GLY
154
n
138
GLY
154
A
PRO
155
n
139
PRO
155
A
TYR
156
n
140
TYR
156
A
ILE
157
n
141
ILE
157
A
LYS
158
n
142
LYS
158
A
ALA
159
n
143
ALA
159
A
ALA
160
n
144
ALA
160
A
VAL
161
n
145
VAL
161
A
THR
162
n
146
THR
162
A
TYR
163
n
147
TYR
163
A
LYS
164
n
148
LYS
164
A
LYS
165
n
149
LYS
165
A
SER
166
n
150
SER
166
A
ASP
167
n
151
ASP
167
A
ASP
168
n
152
ASP
168
A
ASP
169
n
153
ASP
169
A
VAL
170
n
154
VAL
170
A
THR
171
n
155
THR
171
A
ILE
172
n
156
ILE
172
A
THR
173
n
157
THR
173
A
SER
174
n
158
SER
174
A
SER
175
n
159
SER
175
A
SER
176
n
160
SER
176
A
VAL
177
n
161
VAL
177
A
TYR
178
n
162
TYR
178
A
THR
179
n
163
THR
179
A
GLY
180
n
164
GLY
180
A
SER
181
n
165
SER
181
A
PRO
182
n
166
PRO
182
A
TYR
183
n
167
TYR
183
A
LEU
184
n
168
LEU
184
A
GLY
185
n
169
GLY
185
A
ASN
186
n
170
ASN
186
A
ASP
187
n
171
ASP
187
A
PRO
188
n
172
PRO
188
A
SER
189
n
173
SER
189
A
PHE
190
n
174
PHE
190
A
SER
191
n
175
SER
191
A
GLY
192
n
176
GLY
192
A
ALA
193
n
177
ALA
193
A
SER
194
n
178
SER
194
A
SER
195
n
179
SER
195
A
VAL
196
n
180
VAL
196
A
SER
197
n
181
SER
197
A
TYR
198
n
182
TYR
198
A
ASP
199
n
183
ASP
199
A
LYS
200
n
184
LYS
200
A
ASP
201
n
185
ASP
201
A
LYS
202
n
186
LYS
202
A
LYS
203
n
187
LYS
203
A
LEU
204
n
188
LEU
204
A
ILE
205
n
189
ILE
205
A
ALA
206
n
190
ALA
206
A
ALA
207
n
191
ALA
207
A
SER
208
n
192
SER
208
A
CYS
209
n
193
CYS
209
A
SER
210
n
194
SER
210
A
GLY
211
n
195
GLY
211
A
THR
212
n
196
THR
212
A
LEU
213
n
197
LEU
213
A
SER
214
n
198
SER
214
A
PHE
215
n
199
PHE
215
A
LYS
216
n
200
LYS
216
A
ASP
217
n
201
ASP
217
A
GLY
218
n
202
GLY
218
A
SER
219
n
203
SER
219
A
ARG
220
n
204
ARG
220
A
LYS
221
n
205
LYS
221
A
VAL
222
n
206
VAL
222
A
GLU
223
n
207
GLU
223
A
VAL
224
n
208
VAL
224
A
THR
225
n
209
THR
225
A
VAL
226
n
210
VAL
226
A
GLN
227
n
211
GLN
227
A
LYS
228
n
212
LYS
228
A
THR
229
n
213
THR
229
A
GLY
230
n
214
GLY
230
A
PHE
231
n
215
PHE
231
A
MSE
232
n
216
MSE
232
A
ILE
233
n
217
ILE
233
A
PRO
234
n
218
PRO
234
A
2.1646
-0.0790
0.0565
2.1458
-0.5020
2.5958
0.0022
-0.3427
-0.4283
0.3511
-0.0696
0.0818
0.2689
0.0283
0.0674
0.1326
-0.0389
0.0216
0.0877
0.0683
0.0905
refined
87.2446
32.9840
-4.0255
X-RAY DIFFRACTION
A
22
A
234
X-RAY DIFFRACTION
1
author_defined_assembly
1
monomeric
software_defined_assembly
PISA
2
dimeric
gel filtration
1410
0
18790
A
MSE
31
SELENOMETHIONINE
A
MSE
15
MET
A
MSE
65
SELENOMETHIONINE
A
MSE
49
MET
A
MSE
232
SELENOMETHIONINE
A
MSE
216
MET
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
-0.5000000000
-0.8660254038
0.0000000000
-0.8660254038
0.5000000000
0.0000000000
0.0000000000
0.0000000000
-1.0000000000
9_764
-x+2,-x+y+1,-z-1/3
crystal symmetry operation
180.0435000000
103.9481631908
-31.5890000000
A
N
VAL
26
A
N
VAL
10
A
O
THR
225
A
O
THR
209
A
O
ILE
233
A
O
ILE
217
A
N
ASN
112
A
N
ASN
96
A
O
GLY
109
A
O
GLY
93
A
N
GLU
70
A
N
GLU
54
A
N
VAL
26
A
N
VAL
10
A
O
THR
225
A
O
THR
209
A
O
VAL
224
A
O
VAL
208
A
N
LEU
213
A
N
LEU
197
A
O
LEU
204
A
O
LEU
188
A
N
ASP
199
A
N
ASP
183
A
N
CYS
146
A
N
CYS
130
A
O
ALA
159
A
O
ALA
143
A
N
LYS
158
A
N
LYS
142
A
O
TYR
178
A
O
TYR
162
1
A
CG
ASN
22
A
CG
ASN
6
1
Y
1
A
OD1
ASN
22
A
OD1
ASN
6
1
Y
1
A
ND2
ASN
22
A
ND2
ASN
6
1
Y
1
A
CG
GLU
23
A
CG
GLU
7
1
Y
1
A
CD
GLU
23
A
CD
GLU
7
1
Y
1
A
OE1
GLU
23
A
OE1
GLU
7
1
Y
1
A
OE2
GLU
23
A
OE2
GLU
7
1
Y
1
A
CD
GLU
35
A
CD
GLU
19
1
Y
1
A
OE1
GLU
35
A
OE1
GLU
19
1
Y
1
A
OE2
GLU
35
A
OE2
GLU
19
1
Y
1
A
CG
ASP
167
A
CG
ASP
151
1
Y
1
A
OD1
ASP
167
A
OD1
ASP
151
1
Y
1
A
OD2
ASP
167
A
OD2
ASP
151
1
Y
1
A
CZ
ARG
220
A
CZ
ARG
204
1
Y
1
A
NH1
ARG
220
A
NH1
ARG
204
1
Y
1
A
NH2
ARG
220
A
NH2
ARG
204
1
Y
1
A
CD
LYS
221
A
CD
LYS
205
1
Y
1
A
CE
LYS
221
A
CE
LYS
205
1
Y
1
A
NZ
LYS
221
A
NZ
LYS
205
1
Y
1
A
GLY
0
A
GLY
1
1
Y
1
A
ALA
18
A
ALA
2
1
Y
1
A
CYS
19
A
CYS
3
1
Y
1
A
GLU
20
A
GLU
4
1
Y
1
A
GLN
21
A
GLN
5
1
Y
1
A
THR
120
A
THR
104
1
Y
1
A
LEU
121
A
LEU
105
1
Y
1
A
SER
122
A
SER
106
1
Y
1
A
ASP
123
A
ASP
107
1
Y
1
A
SER
124
A
SER
108
1
Y
1
A
GLN
125
A
GLN
109
1
Y
1
A
TYR
126
A
TYR
110
1
Y
1
A
PHE
127
A
PHE
111
1
Y
1
A
GLY
128
A
GLY
112
1
Y
1
A
ARG
129
A
ARG
113
1
Y
1
A
ILE
130
A
ILE
114
1
Y
1
A
ALA
131
A
ALA
115
1
Y
1
A
THR
132
A
THR
116
1
Y
1
A
ARG
133
A
ARG
117
1
Y
1
A
SER
134
A
SER
118
1
Y
1
A
PRO
135
A
PRO
119
1
Y
1
A
GLU
136
A
GLU
120
1
Y
1
A
GLY
137
A
GLY
121
1
Y
1
A
GLY
138
A
GLY
122
1
Y
1
A
A
CB
SG
CYS
CYS
146
146
-0.233
0.016
1.812
1.579
N
1
A
A
NE
NE
ARG
ARG
220
220
2.11
1_555
10_664
1
A
SER
51
-59.81
-8.22
1
A
LYS
77
-89.64
36.66
1
A
ILE
104
-106.23
79.44
1
A
ASP
117
-39.23
121.22
1
A
CYS
146
-171.94
127.29
1
A
ASP
217
-112.37
70.25
86.95
39.252
10.55
1.280
0.640
0.000
1.280
0.000
-1.920
0.946
0.922
1. HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. 2. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET INCORPORATION. 3. ATOM RECORDS CONTAIN RESIDUAL B FACTORS ONLY.
0.239
0.202
0.204
2.600
28.831
629
12878
4.900
99.870
1.00
0.50
18.125
0.171
RANDOM
LIKELY RESIDUAL
1
THROUGHOUT
0.00
MAD
0.269
0.224
0.800
0.800
1.200
MAXIMUM LIKELIHOOD WITH PHASES
MASK
2.600
28.831
0
1526
0
0
1526
0.015
0.022
1573
0.002
0.020
1068
1.536
1.959
2132
0.819
3.000
2620
5.773
5.000
194
33.512
25.294
68
16.351
15.000
274
11.566
15.000
4
0.084
0.200
231
0.006
0.021
1736
0.001
0.020
304
1.675
3.000
970
0.313
3.000
390
3.187
5.000
1575
5.109
8.000
603
7.184
11.000
556
0.407
0.361
2.667
45
894
939
20
99.790
2.60
28.831
3KNY
12900
0.124
0.124
1
16.700
10.500
99.900
0.011
2.60
2.67
0.7
10029
941
1.056
1
10.70
100.00
0.011
2.67
2.74
0.9
9701
902
0.822
1
10.80
100.00
0.011
2.74
2.82
1.1
9399
870
0.692
1
10.80
100.00
0.011
2.82
2.91
1.4
9369
866
0.564
1
10.80
100.00
0.011
2.91
3.00
1.8
9033
842
0.440
1
10.70
100.00
0.011
3.00
3.11
2.4
8566
790
0.326
1
10.80
100.00
0.011
3.11
3.22
3.0
8399
784
0.259
1
10.70
100.00
0.011
3.22
3.36
3.8
8120
763
0.199
1
10.60
100.00
0.011
3.36
3.51
4.7
7630
715
0.154
1
10.70
100.00
0.011
3.51
3.68
5.8
7463
700
0.125
1
10.70
100.00
0.011
3.68
3.88
6.7
7087
672
0.109
1
10.50
100.00
0.011
3.88
4.11
7.7
6580
621
0.094
1
10.60
100.00
0.011
4.11
4.39
9.1
6332
604
0.074
1
10.50
100.00
0.011
4.39
4.75
10.8
5902
567
0.063
1
10.40
100.00
0.011
4.75
5.20
10.8
5322
513
0.061
1
10.40
100.00
0.011
5.20
5.81
9.6
4904
478
0.070
1
10.30
100.00
0.011
5.81
6.71
9.2
4280
429
0.073
1
10.00
100.00
0.011
6.71
8.22
10.1
3576
364
0.063
1
9.80
100.00
0.011
8.22
11.63
10.9
2841
304
0.053
1
9.30
100.00
0.011
11.63
28.83
12.4
1398
175
0.048
1
8.00
93.80
refinement
Garib N. Murshudov
garib@ysbl.york.ac.uk
Fortran_77
http://www.ccp4.ac.uk/dist/html/refmac5.html
REFMAC
program
5.5.0053
refinement
P.D. Adams
PDAdams@lbl.gov
C++
http://www.phenix-online.org/
PHENIX
package
phasing
George M. Sheldrick
gsheldr@shelx.uni-ac.gwdg.de
Fortran_77
http://shelx.uni-ac.gwdg.de/SHELX/
SHELX
package
model building
D.C. & J.S. Richardson lab
molprobity@kinemage.biochem.duke.edu
http://kinemage.biochem.duke.edu/molprobity/
MolProbity
package
3beta29
data scaling
Phil R. Evans
pre@mrc-lmb.cam.ac.uk
5/04/2004
Fortran_77
http://www.ccp4.ac.uk/dist/html/scala.html
SCALA
other
3.2.5
data extraction
PDB
help@deposit.rcsb.org
June 11, 2008
C++
http://sw-tools.pdb.org/apps/PDB_EXTRACT/
PDB_EXTRACT
package
3.006
data reduction
MOSFLM
phasing
SHELXD
phasing
autoSHARP
Crystal structure of a two domain protein with unknown function (bt_3535) from bacteroides thetaiotaomicron vpi-5482 at 2.60 A resolution
1
N
N
ANALYTICAL SIZE-EXCLUSION CHROMATOGRAPHY SUPPORTS THE ASSIGNMENT OF A MONOMER AS THE SIGNIFICANT OLIGOMERIC FORM IN SOLUTION.
A
SER
33
A
SER
17
HELX_P
A
ASN
37
A
ASN
21
5
1
5
A
PRO
47
A
PRO
31
HELX_P
A
LYS
53
A
LYS
37
5
2
7
A
THR
55
A
THR
39
HELX_P
A
SER
66
A
SER
50
1
3
12
A
TYR
73
A
TYR
57
HELX_P
A
LYS
77
A
LYS
61
5
4
5
A
SER
81
A
SER
65
HELX_P
A
LYS
101
A
LYS
85
1
5
21
covale
1.334
both
A
MSE
31
A
C
MSE
15
1_555
A
GLN
32
A
N
GLN
16
1_555
covale
1.335
both
A
MSE
65
A
C
MSE
49
1_555
A
SER
66
A
N
SER
50
1_555
covale
1.336
both
A
MSE
232
A
C
MSE
216
1_555
A
ILE
233
A
N
ILE
217
1_555
UNKNOWN FUNCTION
Structural genomics, Joint Center for Structural Genomics, JCSG, Protein Structure Initiative, PSI-2, unknown function
Q8A1X3_BACTN
UNP
1
18
Q8A1X3
ACEQNEDWVVNEPMQSFEENPEYAPLNTIPDWVSEKVTPKEYELWRTMSSRYEINYSFLKKDISEKRKKEIYDCINNICE
RIEKGQINKYEGFLNIADEDGTTLSDSQYFGRIATRSPEGGAEYKTNGCTLYTHSLGPYIKAAVTYKKSDDDVTITSSSV
YTGSPYLGNDPSFSGASSVSYDKDKKLIAASCSGTLSFKDGSRKVEVTVQKTGFMIP
18
234
3KNY
18
234
Q8A1X3
A
1
2
218
1
expression tag
GLY
0
3KNY
A
Q8A1X3
UNP
1
4
4
3
parallel
parallel
parallel
parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
GLU
23
A
GLU
7
A
VAL
26
A
VAL
10
A
ARG
220
A
ARG
204
A
ILE
233
A
ILE
217
A
GLY
109
A
GLY
93
A
ILE
113
A
ILE
97
A
TYR
69
A
TYR
53
A
ILE
71
A
ILE
55
A
GLU
23
A
GLU
7
A
VAL
26
A
VAL
10
A
ARG
220
A
ARG
204
A
ILE
233
A
ILE
217
A
LEU
204
A
LEU
188
A
ASP
217
A
ASP
201
A
SER
189
A
SER
173
A
ASP
199
A
ASP
183
A
GLU
140
A
GLU
124
A
THR
150
A
THR
134
A
TYR
156
A
TYR
140
A
LYS
165
A
LYS
149
A
VAL
170
A
VAL
154
A
GLY
180
A
GLY
164
181
P 64 2 2